
Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

